Curated News
By: NewsRamp Editorial Staff
July 25, 2024
Mango Rx CEO Discusses Men's Telehealth Initiatives on Benzinga's All-Access
Discuss on Reddit
LinkedIn
Substack
GithubTLDR
- Invest in Mango Rx (NASDAQ: MGRX) for potential growth in the men's wellness telemedicine sector.
- Mango Rx focuses on men's health and wellness products via secure telemedicine, including erectile dysfunction, hair growth, and hormone replacement therapies.
- Mango Rx's telemedicine products and services aim to improve men's health and wellness, making tomorrow better than today.
- Mango Rx CEO, Jacob Cohen, discusses the company's focus on men's health and wellness products and services on Benzinga’s All-Access.
Impact - Why it Matters
This news matters as it sheds light on a unique approach to men's telehealth and wellness products, addressing important issues such as erectile dysfunction and hormone replacement therapies.
Summary
Jacob Cohen, CEO of Mango Rx (NASDAQ: MGRX), was recently a guest on Benzinga’s All-Access. Mangoceuticals is focused on developing men's health and wellness products and services via a secure telemedicine platform, with a particular focus on erectile dysfunction, hair growth, and hormone replacement therapies.
Source Statement
This curated news summary relied on this press release disributed by News Direct. Read the source press release here, Mango Rx CEO Discusses Men's Telehealth Initiatives on Benzinga's All-Access
